Hand dermatitis (HD), also known as hand eczema, is a common dermatologic disorder (Warshaw, Lee, & Storrs, 2003). It is a frequent problem among individuals who perform "wet work" such as ...
RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for 12 of 15 patients within four weeks. The condition primarily affects ...
People with chronic hand eczema (CHE) have reported the serious impact the condition can have on their daily lives in a UK survey. The poll – commissioned by LEO Pharma and supported by Allergy ...
Eczema, a prevalent skin condition affecting millions worldwide, is characterized by dry, itching, and inflamed skin, frequently appearing on hands. Incorrect use of hand soap can exacerbate ...
Wouldn’t it be great to sail through the rest of winter with soft skin? For the 78 percent of us bothered by itchy or sore patches caused by cold weather and dry indoor air, help is here! Whether you ...
Emotional stress can make pomphylox worse. In the United States, pomphylox occurs in as many as 5% to 20% of patients with hand eczema and more commonly occurs in warmer climates and during spring ...
Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
The phase 3 DELTA TEEN trial evaluating Anzupgo 20 mg/g cream for the treatment of chronic hand eczema in adolescents has shown positive results, LEO Pharma announced in a press release. The 16-week, ...